- Home
- ARVN vs EDN Comparison
ARVN vs EDN Comparison
Compare ARVN & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- EDN
- Stock Information
- Founded
- ARVN 2015
- EDN 1992
- Country
- ARVN United States
- EDN Argentina
- Employees
- ARVN N/A
- EDN N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- EDN Electric Utilities: Central
- Sector
- ARVN Health Care
- EDN Utilities
- Exchange
- ARVN Nasdaq
- EDN Nasdaq
- Market Cap
- ARVN 1.2B
- EDN 1.3B
- IPO Year
- ARVN 2018
- EDN 2007
- Fundamental
- Price
- ARVN $7.02
- EDN $30.53
- Analyst Decision
- ARVN Buy
- EDN
- Analyst Count
- ARVN 13
- EDN 0
- Target Price
- ARVN $34.42
- EDN N/A
- AVG Volume (30 Days)
- ARVN 3.5M
- EDN 106.6K
- Earning Date
- ARVN 05-06-2025
- EDN 03-11-2025
- Dividend Yield
- ARVN N/A
- EDN N/A
- EPS Growth
- ARVN N/A
- EDN 42.19
- EPS
- ARVN N/A
- EDN 0.30
- Revenue
- ARVN $263,399,999.00
- EDN $1,981,694,257.00
- Revenue This Year
- ARVN N/A
- EDN $51.74
- Revenue Next Year
- ARVN $7.99
- EDN N/A
- P/E Ratio
- ARVN N/A
- EDN $6.35
- Revenue Growth
- ARVN 235.54
- EDN 33.82
- 52 Week Low
- ARVN $6.88
- EDN $13.78
- 52 Week High
- ARVN $41.34
- EDN $51.69
- Technical
- Relative Strength Index (RSI)
- ARVN 23.50
- EDN 38.40
- Support Level
- ARVN $8.51
- EDN $31.20
- Resistance Level
- ARVN $9.17
- EDN $35.20
- Average True Range (ATR)
- ARVN 0.55
- EDN 1.78
- MACD
- ARVN -0.05
- EDN -0.01
- Stochastic Oscillator
- ARVN 5.24
- EDN 17.78
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.